Select Page

USA FDA requests postmarket studies on positive displacement needleless connector risks

Home Forums Infexion Connexion USA FDA requests postmarket studies on positive displacement needleless connector risks

 | Click to Receive Email Notifications of Posts
  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #68387
    Wishart, Michael
    Participant

    Author:
    Wishart, Michael

    Position:

    Organisation:

    State:

    The US FDA has sent an open letter to US ICP’s about the possible risk
    of bacteraemia in patients with positive displacement needleless
    connectors. They have also requested further postmarket studies by some
    specific manufacturers to ascertain the level of risk as compared to
    other needleless technologies.

    ‘Because there is presently insufficient information to determine if
    positive displacement connectors increase the risk of BSI compared with
    other needleless connectors, FDA is requiring the companies to conduct
    postmarket surveillance studies to provide an assessment of the risk
    associated with positive displacement needleless connectors.’

    They have not currently advised any changes in practices or use of
    positive displacement needleless connectors, but that current SHEA/IDSA
    recommendations should be followed.

    http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm220459.htm

    Definitely worth keeping an eye on!

    Cheers
    Michael

    Michael Wishart | GPH – Infection Control Coordinator

    GPH – Quality & Safety Unit (Infection Control) | Greenslopes Private
    Hospital
    Newdegate Street, Greenslopes QLD 4120
    t: 07 3394 7919 | f: 07 3394 7985
    e: WishartM@ramsayhealth.com.au | w: http://www.ramsayhealth.com.au

    Ramsay Health Care is an environmentally responsible corporation, please
    consider the environment before printing this email.

    This e-mail message and any accompanying files may contain
    information that is confidential and subject to privilege. If you
    are not the intended recipient, and have received the e-mail
    in error, you are notified that any use, dissemination,
    distribution, forwarding, printing or copying of the message
    and any attached files is strictly prohibited. If you have
    received this e-mail message in error please immediately
    advise the sender by return e-mail, or telephone 1800 243 903.
    You must destroy the original transmission and its contents.
    Any views expressed within this communication are those of
    the individual sender, except where the sender specifically
    states them to be the views of Ramsay Health Care.
    This communication should not be copied or disseminated
    without permission.
    ————————————————————————

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of AICA.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 1 post (of 1 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.